Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-110341
Filing Date
2025-08-19
Accepted
2025-08-19 21:21:47
Documents
2
Period of Report
2025-08-15

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 10448
2 EX-24.1 ivvd-ex24_1.htm EX-24.1 19851
  Complete submission text file 0000950170-25-110341.txt   31834
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Invivyd, Inc. (Issuer) CIK: 0001832038 (see all company filings)

EIN.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451
Business Address
Andersen Jill (Reporting) CIK: 0001891047 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40703 | Film No.: 251233635